TSI HEALTH SCIENCES (EUROPE) LIMITED
Get an alert when TSI HEALTH SCIENCES (EUROPE) LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-04-16 (in 11mo)
Last made up 2026-04-02
Watchouts
None on the register
Cash
£3M
+25.3% vs 2023
Net assets
£579K
+2.1% vs 2023
Employees
8
0% vs 2023
Profit before tax
£15K
+247.9% vs 2023
Net assets
5-year trend · vs Consumer Discretionary median
Accounts
5-year trend · latest reflected 2024-12-31
| Metric | Trend | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Turnover | — | — | — | £18,595,198 | £20,728,372 | |
| Operating profit | — | — | — | -£8,719 | £14,867 | |
| Profit before tax | — | — | — | -£10,050 | £14,867 | |
| Net profit | — | — | — | -£11,424 | £12,011 | |
| Cash | — | — | — | £2,036,386 | £2,552,227 | |
| Total assets less current liabilities | — | — | — | £566,831 | £578,842 | |
| Net assets | — | — | — | £566,831 | £578,842 | |
| Equity | — | — | — | £566,831 | £578,842 | |
| Average employees | — | — | — | 8 | 8 | |
| Wages | — | — | — | £448,386 | £436,829 | |
| Directors' remuneration | — | — | — | £135,730 | £150,782 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+11.5%
£18,595,198 £20,728,372
-
Cash
+25.3%
£2,036,386 £2,552,227
-
Net assets
+2.1%
£566,831 £578,842
-
Employees
0%
8 8
-
Operating profit
+270.5%
-£8,719 £14,867
-
Profit before tax
+247.9%
-£10,050 £14,867
-
Wages
-2.6%
£448,386 £436,829
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Operating margin | — | — | — | -0.0% | 0.1% | |
| Net margin | — | — | — | -0.1% | 0.1% | |
| Return on capital employed | — | — | — | -1.5% | 2.6% | |
| Current ratio | — | — | — | 1.06x | 1.05x | |
| Interest cover | — | — | — | -6.55x | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- TSI HEALTH SCIENCES (EUROPE) LIMITED 2006-04-29 → present
- KEGS R US LIVERPOOL LIMITED 2005-06-14 → 2006-04-29
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Barlow Andrews LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.”
Group structure
- TSI HEALTH SCIENCES (EUROPE) LIMITED · parent
- FMC Pharma Limited 100%
Significant events
- “In 2024 the revenue grew by 11% in comparison with the prior year, as a result of marketing efforts and participation in pharmaceutical exhibitions. However, profit margins remained under pressure as costs kept rising. Despite this, we benefited from higher sales volumes and an expanding customer base.”
- “The new trade agreement between the UK and the EU could result in an increase in the cost of imports due to duties/tariffs. however any impact is not expected to be significant and can be mitigated by the continental European warehousing and distribution the business has in place.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 3 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| SUNDERLAND, Michael John | Director | 2021-10-01 | Sep 1977 | British |
| ZHOU, Jingshi Joe | Director | 2019-01-01 | Nov 1962 | American |
Show 3 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| T.I.B. SECRETARIES LIMITED | Corporate Secretary | 2005-06-14 | 2010-06-16 |
| LINDRIDGE, Adrian Stewart | Director | 2006-04-29 | 2021-10-15 |
| T.I.B. NOMINEES LIMITED | Corporate Director | 2005-06-14 | 2006-04-29 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Hygieia Health Co Ltd | Corporate entity | Shares 75–100% | 2020-01-01 | Ceased 2020-01-01 |
| Ms Ling Long | Individual | Shares 25–50% | 2018-08-29 | Ceased 2022-01-28 |
| Mr Larry Jonathan Kolb | Individual | right-to-appoint-and-remove-directors-as-firm | 2016-04-06 | Ceased 2022-01-28 |
| Tsi Group Ltd | Corporate entity | Shares 75–100%, right-to-appoint-and-remove-directors-as-firm, significant-influence-or-control-as-firm | 2016-04-06 | Ceased 2016-04-06 |
| Mr Joe Jingshi Zhou | Individual | right-to-appoint-and-remove-directors-as-firm, significant-influence-or-control-as-firm | 2016-04-06 | Ceased 2016-04-06 |
Filing timeline
Last 20 of 70 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-04-08 | AA | accounts | Accounts with accounts type full | |
| 2025-04-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-16 | AA | accounts | Accounts with accounts type full | |
| 2024-04-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-06-30 | AA | accounts | Accounts with accounts type full | |
| 2023-04-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-28 | AA | accounts | Accounts with accounts type full | |
| 2022-04-29 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-03-07 | PSC08 | persons-with-significant-control | Notification of a person with significant control statement | |
| 2022-03-04 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2022-03-04 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2021-12-30 | AA | accounts | Accounts with accounts type full | |
| 2021-11-23 | AD01 | address | Change registered office address company with date old address new address | |
| 2021-10-30 | TM01 | officers | Termination director company with name termination date | |
| 2021-10-22 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2021-10-22 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2021-10-22 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2021-10-22 | AP01 | officers | Appoint person director company with name date | |
| 2021-06-07 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 1
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.